{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T07:10:28Z","timestamp":1779433828266,"version":"3.53.1"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"51","license":[{"start":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T00:00:00Z","timestamp":1766102400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Key Research and Development Program Project of Heilongjiang Province","award":["2023ZX06C13"],"award-info":[{"award-number":["2023ZX06C13"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,12,19]]},"abstract":"<jats:sec>\n                    <jats:title>Rationale:<\/jats:title>\n                    <jats:p>Small-cell carcinoma of the ovary, hypercalcemic type (SCCOHT) is an extremely rare and aggressive ovarian malignancy associated with SMARCA4 mutation, accounting for less than 0.01% of ovarian tumors. It predominantly affects young females and is characterized by poor prognosis. Here, we report a unique case of SCCOHT with a special pathological classification of large cell variant type in a 59-year-old postmenopausal woman, an age that is rare for this disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patient concerns:<\/jats:title>\n                    <jats:p>A 59-year-old female patient presented with lower abdominal pain. A hard and restricted mass was palpated at the back of the uterus during pelvic physical examination. MRI examination showed a huge solid mixed-signal mass shadow in the right adnexal area, with a size of 10\u2005\u00d7\u20057\u2005\u00d7\u20057\u2009cm.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Diagnoses:<\/jats:title>\n                    <jats:p>Postoperative histopathological and immunohistochemical analyses demonstrated abundant large cells under microscopic examination and a loss of BRG1 protein expression, leading to the diagnosis of large cell variant of SCCOHT in right ovary. Genetic testing confirmed a mutation in the SMARCA4 gene (exon 6, c.1103del p.[Q368Rfs*43]).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions:<\/jats:title>\n                    <jats:p>The patient underwent pelvic tumor cytoreductive surgery and pelvic adhesion release surgery, and the implanted lesions in the pelvic cavity were resected during the operation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Outcomes:<\/jats:title>\n                    <jats:p>The patient underwent extensive surgical resection and completed 6 cycles of TC chemotherapy (paclitaxel\u2005+\u2005carboplatin). Despite the postoperative pathological stage reached Stage II, during the 18-month follow-up after the operation, no evidence of tumor progression or recurrence was observed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Lessons:<\/jats:title>\n                    <jats:p>SCCOHT is a highly malignant tumor associated with a generally poor prognosis, particularly for tumors at stage II or higher. Nevertheless, the favorable prognosis observed in this case suggests that the traditional understanding may require reevaluation. Whether there is a correlation between the age of onset of SCCOHT and the prognosis remains to be elucidated through systematic clinical research in the future.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000046423","type":"journal-article","created":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T04:01:11Z","timestamp":1766203271000},"page":"e46423","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["A rare large cell variant of small-cell carcinoma of the ovary, hypercalcemic type in a postmenopausal woman: Case report"],"prefix":"10.1097","volume":"104","author":[{"given":"Simeng","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Radiology, Sixth Affiliated Hospital of Harbin Medical University, Harbin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuping","family":"Che","sequence":"additional","affiliation":[{"name":"Department of Radiology, First Affiliated Hospital of Harbin Medical University, Harbin, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuicui","family":"Jin","sequence":"additional","affiliation":[{"name":"Department of Radiology, Sixth Affiliated Hospital of Harbin Medical University, Harbin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhui","family":"Deng","sequence":"additional","affiliation":[{"name":"Department of Radiology, Sixth Affiliated Hospital of Harbin Medical University, Harbin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6193-6361","authenticated-orcid":false,"given":"Deli","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Radiology, Sixth Affiliated Hospital of Harbin Medical University, Harbin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260522","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ygyno.2015.11.004","article-title":"Small cell carcinoma of the ovary-hypercalcemic type (SCCOHT): a review of 47 cases.","volume":"140","author":"Callegaro-Filho","year":"2016","journal-title":"Gynecol Oncol"},{"key":"R2-20260522","doi-asserted-by":"crossref","first-page":"3908","DOI":"10.1158\/1078-0432.CCR-19-3797","article-title":"Small-cell carcinoma of the ovary, hypercalcemic type-genetics, new treatment targets, and current management guidelines.","volume":"26","author":"Tischkowitz","year":"2020","journal-title":"Clin Cancer Res"},{"key":"R3-20260522","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jpag.2022.10.004","article-title":"Small cell carcinoma of ovary, hypercalcemic type: a rare case report.","volume":"36","author":"Co\u015fkun","year":"2023","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"R4-20260522","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1158\/1535-7163.MCT-21-0433","article-title":"SMARCA4: implications of an altered chromatin-remodeling gene for cancer development and therapy.","volume":"20","author":"Mardinian","year":"2021","journal-title":"Mol Cancer Ther"},{"key":"R5-20260522","doi-asserted-by":"crossref","first-page":"e96","DOI":"10.3802\/jgo.2024.35.e96","article-title":"Clinical characteristics and status of treatment of small-cell carcinoma of the ovary, hypercalcemic type in the Chinese population: a meta-analysis.","volume":"35","author":"Zheng","year":"2024","journal-title":"J Gynecol Oncol"},{"key":"R6-20260522","doi-asserted-by":"crossref","first-page":"191","DOI":"10.6004\/jnccn.2021.0007","article-title":"Ovarian cancer, Version 2.2020, NCCN clinical practice guidelines in oncology.","volume":"19","author":"Armstrong","year":"2021","journal-title":"J Natl Compr Canc Netw"},{"key":"R7-20260522","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/his.13977","article-title":"Revising the WHO classification: female genital tract tumours.","volume":"76","author":"Cree","year":"2020","journal-title":"Histopathology"},{"key":"R8-20260522","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/ng.2931","article-title":"Germline and somatic SMARCA4 mutations characterize small cell carcinoma of the ovary, hypercalcemic type.","volume":"46","author":"Witkowski","year":"2014","journal-title":"Nat Genet"},{"key":"R9-20260522","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1146\/annurev-pathmechdis-012418-012917","article-title":"SWI\/SNF complex mutations in gynecologic cancers: molecular mechanisms and models.","volume":"15","author":"Wang","year":"2020","journal-title":"Annu Rev Pathol"},{"key":"R10-20260522","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1111\/his.13177","article-title":"Clinical, morphological and immunohistochemical evidence that small-cell carcinoma of the ovary of hypercalcaemic type (SCCOHT) may be a primitive germ-cell neoplasm.","volume":"70","author":"McCluggage","year":"2017","journal-title":"Histopathology"},{"key":"R11-20260522","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jpag.2020.07.017","article-title":"Small cell carcinoma of ovary, hypercalcemic type: cytologic, histopathologic, and immunohistochemical landscapes of a rare case.","volume":"34","author":"Aggarwal","year":"2021","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"R12-20260522","doi-asserted-by":"crossref","first-page":"1103429","DOI":"10.3389\/fendo.2023.1103429","article-title":"Prognosis comparison between small cell carcinoma of ovary and high-grade serous ovarian cancer: a retrospective observational cohort study.","volume":"14","author":"Hu","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R13-20260522","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/PAS.0000000000002296","article-title":"Additional considerations on aberrant BRG1 (SMARCA4) expression in Small Cell Carcinoma of the Ovary, Hypercalcemic Type (SCCOHT).","volume":"48","author":"Cyrta","year":"2024","journal-title":"Am J Surg Pathol"},{"key":"R14-20260522","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1067\/j.cpradiol.2017.08.004","article-title":"Small cell carcinoma of the ovary, hypercalcemic type: clinical and imaging review.","volume":"47","author":"Korivi","year":"2018","journal-title":"Curr Probl Diagn Radiol"},{"key":"R15-20260522","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.ygyno.2020.06.160","article-title":"Small cell carcinoma of the ovary hypercalcemic type (SCCOHT): comprehensive management of a newly diagnosed young adult.","volume":"158","author":"Pressey","year":"2020","journal-title":"Gynecol Oncol"},{"key":"R16-20260522","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1097\/00000478-199411000-00004","article-title":"Small cell carcinoma of the ovary, hypercalcemic type. a clinicopathological analysis of 150 cases.","volume":"18","author":"Young","year":"1994","journal-title":"Am J Surg Pathol"},{"key":"R17-20260522","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.ygyno.2018.02.004","article-title":"Small cell cancers of the female genital tract: molecular and clinical aspects.","volume":"149","author":"Patibandla","year":"2018","journal-title":"Gynecol Oncol"},{"key":"R18-20260522","doi-asserted-by":"crossref","first-page":"223","DOI":"10.7150\/jca.26978","article-title":"An In-Depth Look at Small Cell Carcinoma of the Ovary, Hypercalcemic Type (SCCOHT): clinical implications from recent molecular findings.","volume":"10","author":"Lu","year":"2019","journal-title":"J Cancer"},{"key":"R19-20260522","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.annpat.2019.02.005","article-title":"SCCOHT\/tumeur rhabdo\u00efde ovarienne: \u00e0 propos d\u2019un cas [SCCOHT\/ovarian rhabdoid tumor: a case report].","volume":"39","author":"Bourgoin","year":"2019","journal-title":"Ann Pathol"},{"key":"R20-20260522","doi-asserted-by":"crossref","first-page":"111778","DOI":"10.1016\/j.ijscr.2025.111778","article-title":"Rapid sequential development of multiple malignancies following ovarian germ cell tumor: diagnostic, therapeutic, and surveillance challenges.","volume":"134","author":"Sheikhhasani","year":"2025","journal-title":"Int J Surg Case Rep"},{"key":"R21-20260522","doi-asserted-by":"crossref","first-page":"3794","DOI":"10.3390\/cancers15153794","article-title":"Small Cell Carcinoma of the Ovary, Hypercalcemic Type (SCCOHT): patient characteristics, treatment, and outcome-a systematic review.","volume":"15","author":"Wens","year":"2023","journal-title":"Cancers (Basel)"},{"key":"R22-20260522","doi-asserted-by":"crossref","first-page":"299","DOI":"10.5858\/arpa.2022-0297-OA","article-title":"A population-based study of patients with small cell carcinoma of the ovary, hypercalcemic type, encompassing a 30-year period.","volume":"148","author":"Blatnik","year":"2024","journal-title":"Arch Pathol Lab Med"},{"key":"R23-20260522","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1158\/1535-7163.MCT-18-0348","article-title":"Histone deacetylase inhibitors synergize with catalytic inhibitors of EZH2 to exhibit antitumor activity in small cell carcinoma of the ovary, hypercalcemic type.","volume":"17","author":"Wang","year":"2018","journal-title":"Mol Cancer Ther"},{"key":"R24-20260522","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1093\/jnci\/djx277","article-title":"Immune-active microenvironment in small cell carcinoma of the ovary, hypercalcemic type: rationale for immune checkpoint blockade.","volume":"110","author":"Jelinic","year":"2018","journal-title":"J Natl Cancer Inst"},{"key":"R25-20260522","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1158\/1078-0432.CCR-17-1928","article-title":"ponatinib shows potent antitumor activity in Small Cell Carcinoma of the Ovary Hypercalcemic Type (SCCOHT) through multikinase inhibition.","volume":"24","author":"Lang","year":"2018","journal-title":"Clin Cancer Res"},{"key":"R26-20260522","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.clnesp.2025.03.023","article-title":"Prognostic significance of the cachexia index (CXI) in patients with cancer: a systematic review and meta-analysis.","volume":"68","author":"Bas","year":"2025","journal-title":"Clin Nutr ESPEN"},{"key":"R27-20260522","doi-asserted-by":"crossref","first-page":"28309","DOI":"10.1038\/s41598-024-71746-z","article-title":"Sex differences in adverse events among cancer patients receiving immune checkpoint inhibitors: the MOUSEION-07 systematic review and meta-analysis.","volume":"14","author":"Vitale","year":"2024","journal-title":"Sci Rep"},{"key":"R28-20260522","doi-asserted-by":"crossref","first-page":"3689","DOI":"10.3390\/cancers16213689","article-title":"Prognostic value of Neutrophil-to-Eosinophil Ratio (NER) in cancer: a systematic review and meta-analysis.","volume":"16","author":"Sahin","year":"2024","journal-title":"Cancers (Basel)"},{"key":"R29-20260522","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.3390\/cancers16101835","article-title":"Prognostic significance of the Royal Marsden Hospital (RMH) score in patients with cancer: a systematic review and meta-analysis.","volume":"16","author":"Sahin","year":"2024","journal-title":"Cancers (Basel)"},{"key":"R30-20260522","doi-asserted-by":"crossref","first-page":"3912","DOI":"10.3390\/jcm11133912","article-title":"Immune checkpoint inhibitors and mismatch repair status in advanced endometrial cancer: elective affinities.","volume":"11","author":"Rizzo","year":"2022","journal-title":"J Clin Med"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000046423","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T07:02:42Z","timestamp":1779433362000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000046423"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,19]]},"references-count":30,"journal-issue":{"issue":"51","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000046423","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,19]]},"assertion":[{"value":"2025-08-01","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-04","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}